Technical Analysis for HBP - Helix BioPharma Corp.

Grade Last Price % Change Price Change
grade A 1.2 3.45% 0.040
HBP closed up 3.45 percent on Friday, October 11, 2019, on 11 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical HBP trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Three Weeks Tight Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.45%
Bollinger Band Squeeze Range Contraction 3.45%
Narrow Range Bar Range Contraction 3.45%
Inside Day Range Contraction 3.45%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.26%

Older signals for HBP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that modulate the tumor microenvironment. The Company's technology platform, DOS47 yielded approximately two drug product candidates, L-DOS47 and vDOS47. L-DOS47 is an antibody protein conjugate where the urease component enzymatically converts naturally occurring urea to ammonia. L-DOS47 is under clinical study for the treatment of non-small cell lung cancer (NSCLC). L-DOS47 has completed preclinical testing and manufacturing development, following which, regulatory approvals are obtained in Poland and the United States to conduct Phase I/II and Phase I clinical studies. V-DOS47 is an antibody DOS47 conjugate that targets the vascular endothelial growth factor 2 receptor (VEGFR2).
Medicine Medical Specialties Cancer Drugs Treatment Of Cancer Cancer Immunotherapy Tumor Monoclonal Antibodies Non Small Cell Lung Cancer Treatment Of Non Small Cell Lung Cancer
Is HBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.29
52 Week Low 0.24
Average Volume 13,528
200-Day Moving Average 0.5991
50-Day Moving Average 0.9542
20-Day Moving Average 1.191
10-Day Moving Average 1.195
Average True Range 0.0667
ADX 22.55
+DI 15.7241
-DI 23.4683
Chandelier Exit (Long, 3 ATRs ) 1.0899
Chandelier Exit (Short, 3 ATRs ) 1.2001
Upper Bollinger Band 1.2669
Lower Bollinger Band 1.1151
Percent B (%b) 0.56
BandWidth 12.745592
MACD Line 0.0645
MACD Signal Line 0.0867
MACD Histogram -0.0221
Fundamentals Value
Market Cap 111.83 Million
Num Shares 93.2 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -9.23
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.320
Resistance 3 (R3) 1.307 1.253 1.300
Resistance 2 (R2) 1.253 1.223 1.260 1.293
Resistance 1 (R1) 1.227 1.204 1.240 1.240 1.287
Pivot Point 1.173 1.173 1.180 1.180 1.173
Support 1 (S1) 1.147 1.143 1.160 1.160 1.113
Support 2 (S2) 1.093 1.124 1.100 1.107
Support 3 (S3) 1.067 1.093 1.100
Support 4 (S4) 1.080